The Royal Pharmaceutical Society (RPS) wants to hear from pharmacy teams to help inform their work with The King’s Fund on the future of pharmacy practice in England. This work aims to set out a vision for the role of pharmacists and pharmacy teams working across all parts of the health and care system, providing [...]
The post RPS wants your views on the future of pharmacy appeared first on PSNC Website.
PSNC, in collaboration with the Association of Independent Multiple Pharmacies, the Company Chemists Association, the National Pharmacy Association, and the Royal Pharmaceutical Society, is supporting an important petition calling for the Government and NHS leaders to act to keep pharmacists safe from violence and abuse. The petition was started by Mike Hewitson, a community pharmacist who has been [...]
The post Pharmacy bodies call on Government to protect pharmacists from violence at work appeared first on PSNC Website.
Since the recent launch of the NHS Profile Manager tool, which uses NHSmail accounts to allow pharmacy team members to login to it, both PSNC and the NHSmail team have received an increasing number of questions from pharmacy contractors regarding NHSmail. NHSmail is an NHS funded and managed secure email service which has been approved [...]
The post New NHSmail FAQs appeared first on PSNC Website.
Community pharmacy contractors are reminded of the Terms of Service requirement to ensure they verify and, where necessary, update the information contained in their NHS website profile and their Directory of Services (DoS) profile at least once each quarter* of the financial year. For the current financial quarter, the deadline for completing this is 30th September 2022. Contractor [...]
The post Reminder: Update NHS website and DoS profile appeared first on PSNC Website.
Class 4 Medicines Defect Information: Rosuvastatin 5 mg, 10 mg and 20 mg film-coated tablets (Accord) Drug alert number: EL (22)A/35 Date issued: 17 August 2022 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Rosuvastatin 5 mg film-coated tablets PL 20075/0402 Batch Number Expiry Date [...]
The post MHRA Class 4 Medicines Defect Information: Rosuvastatin 5 mg, 10 mg and 20 mg film-coated tablets appeared first on PSNC Website.
Recent Comments